You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

Akorn Inc Company Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for AKORN INC, and what generic and branded alternatives to AKORN INC drugs are available?

AKORN INC has thirty-three approved drugs.

There are two tentative approvals on AKORN INC drugs.

Summary for Akorn Inc
US Patents:0

Drugs and US Patents for Akorn Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn Inc GRANISETRON HYDROCHLORIDE granisetron hydrochloride INJECTABLE;INJECTION 079119-001 Sep 10, 2009 AP RX No No   Start Trial   Start Trial
Akorn Inc DILTIAZEM HYDROCHLORIDE diltiazem hydrochloride INJECTABLE;INJECTION 075086-001 Apr 9, 1998 AP RX No No   Start Trial   Start Trial
Akorn Inc PANTOPRAZOLE SODIUM pantoprazole sodium INJECTABLE;IV (INFUSION) 079197-001 Nov 8, 2012 AP RX No No   Start Trial   Start Trial
Akorn Inc PROPARACAINE HYDROCHLORIDE proparacaine hydrochloride SOLUTION/DROPS;OPHTHALMIC 040277-001 Mar 16, 2000 AT RX No Yes   Start Trial   Start Trial
Akorn Inc TOBRAMYCIN tobramycin SOLUTION;INHALATION 201422-001 May 28, 2014 AN RX No No   Start Trial   Start Trial
Akorn Inc CEFTRIAXONE ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 065305-001 Jan 11, 2008 AP RX No No   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.